BICLUSTER_ID : UPREG-82
PATHOGENS /3/ : streptococcus pneumoniae,yersinia enterocolitica,mycobacterium tuberculosis
TARGETS /6/ : IL6, CCL20, PTGS2, JUN, PIM1, PLAUR
Gene SetLeading Edge Genes
NETPATH IL 1 PATHWAY UPNR4A3, RHOB, CCL20, JUN, CXCL1, HBEGF, FOSL1, IL6, PTGS2, ZFP36, INHBA, CXCL2
NETPATH TNF ALPHA PATHWAY DOWNCCL20, JUN, RGS16, EGR1, CXCL2, BHLHB2, IER3, KLF6, CXCL1, JUNB, TIPARP, EGR3, MAFF, DUSP2, GEM, IL6, PTGS2, TNFAIP3, CTGF, ZFP36
NETPATH IL 2 PATHWAY UPKLF6, JUN, GADD45G, RGS16, PMAIP1, NFIL3, NR4A2, IL6, PIM1, BHLHB2, PLAUR, IER3
NETPATH IL 4 PATHWAY UPMXD1, JUN, IBRDC3, ELL2, NFIL3, IL6, INHBA, EGR2
GERY CEBP TARGETSGADD45B, CXCL1, JUNB, HBEGF, GADD45G, RGS16, ATF3, PIM1, DUSP1, PLAUR
NETPATH IL 4 PATHWAY DOWNGEM, CCL20, GADD45B, PTGS2, CDKN1A, CXCL2
NETPATH KIT RECEPTOR PATHWAY UPGDF15, IL6, EGR1, JUNB, PIM1, IER3
NETPATH IL 6 PATHWAY UPGADD45B, CXCL1, JUN, JUNB, HBEGF, MAP3K8, MAFF, ZFP36, PIM1, BHLHB2
NETPATH EGFR1 PATHWAY UPSNAI1, NR4A3, PHLDA1, CDKN1A, EREG, HBEGF, SPRY2, EGR1, PTGS2, TNFAIP3, CTGF, DUSP1, PLAUR, IER3
NETPATH WNT PATHWAY UPTWIST1, RHOB, JUN, MAPK6, CREM, PLAUR, DUSP1
NETPATH IL 7 PATHWAY UPCXCL1, JUN, CXCL2
NETPATH IL 3 PATHWAY UPNFIL3, PIM1
NETPATH IL 5 PATHWAY UPHBEGF, MAPK6, NFIL3, EGR3, EGR1, PIM1, IER3, EGR2
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
NETPATH IL 9 PATHWAY UP
MAHAJAN RESPONSE TO IL1A UP
LINDGREN BLADDER CANCER CLUSTER 2B
VANHARANTA UTERINE FIBROID DN
CHUANG OXIDATIVE STRESS RESPONSE UP
VARELA ZMPSTE24 TARGETS UP
CHEN LVAD SUPPORT OF FAILING HEART UP
TENEDINI MEGAKARYOCYTE MARKERS
LINDSTEDT DENDRITIC CELL MATURATION B
RASHI RESPONSE TO IONIZING RADIATION 2
LINDSTEDT DENDRITIC CELL MATURATION A
BASAKI YBX1 TARGETS DN
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
ODONNELL TFRC TARGETS UP
ELVIDGE HYPOXIA UP
GRAHAM CML QUIESCENT VS NORMAL QUIESCENT DN
SESTO RESPONSE TO UV C0
IYENGAR RESPONSE TO ADIPOCYTE FACTORS
VALK AML CLUSTER 1
AMIT EGF RESPONSE 40 HELA
MISHRA CARCINOMA ASSOCIATED FIBROBLAST UP
JEON SMAD6 TARGETS UP
LIN SILENCED BY TUMOR MICROENVIRONMENT
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
BOYAULT LIVER CANCER SUBCLASS G56 DN
HINATA NFKB TARGETS KERATINOCYTE UP
DORN ADENOVIRUS INFECTION 48HR DN
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
OSADA ASCL1 TARGETS DN
AMIT SERUM RESPONSE 60 MCF10A
DAVICIONI PAX FOXO1 SIGNATURE IN ARMS DN
DUTTA APOPTOSIS VIA NFKB
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS MAGENTA UP
DIRMEIER LMP1 RESPONSE EARLY
DER IFN GAMMA RESPONSE UP
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY DN
SEMENZA HIF1 TARGETS
NCI NFAT TFPATHWAY
ZHOU INFLAMMATORY RESPONSE LIVE UP
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 DN
ONDER CDH1 TARGETS 3 DN
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLUE UP
AMIT EGF RESPONSE 120 HELA
BIOCARTA RANKL PATHWAY
DANG REGULATED BY MYC DN
VART KSHV INFECTION ANGIOGENIC MARKERS DN
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
DAZARD RESPONSE TO UV NHEK UP
MCLACHLAN DENTAL CARIES UP
WINTER HYPOXIA METAGENE
GAJATE RESPONSE TO TRABECTEDIN UP
NEWMAN ERCC6 TARGETS UP
PODAR RESPONSE TO ADAPHOSTIN UP
SHAFFER IRF4 TARGETS IN PLASMA CELL VS MATURE B LYMPHOCYTE
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS TURQUOISE UP
FOSTER INFLAMMATORY RESPONSE LPS DN
LEE LIVER CANCER E2F1 UP
TAVOR CEBPA TARGETS UP
GAURNIER PSMD4 TARGETS
KERLEY RESPONSE TO CISPLATIN UP
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
ZHOU INFLAMMATORY RESPONSE LPS UP
GESERICK TERT TARGETS DN
SUNG METASTASIS STROMA UP
NETPATH TGFBETA RECEPTOR PATHWAY DOWN
NGUYEN NOTCH1 TARGETS DN
CLASPER LYMPHATIC VESSELS DURING METASTASIS UP
AMIT SERUM RESPONSE 120 MCF10A
BROWNE HCMV INFECTION 2HR UP
NETPATH IL 3 PATHWAY DOWN
SASSON RESPONSE TO GONADOTROPHINS DN
DORN ADENOVIRUS INFECTION 24HR DN
HALMOS CEBPA TARGETS DN
ZIRN TRETINOIN RESPONSE UP
SESTO RESPONSE TO UV C3
FALVELLA SMOKERS WITH LUNG CANCER
VERHAAK AML WITH NPM1 MUTATED UP
AMIT EGF RESPONSE 40 MCF10A
BROCKE APOPTOSIS REVERSED BY IL6
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
NCI P53DOWNSTREAMPATHWAY
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX RPL6 RPL30 RPS13 CHUK DDX3X NFKB2 NFKBIB REL IKBKG NFKB1 MAP3K8 RELB GLG1 NFKBIA RELA TNIP2 GTF2I
GENTILE UV HIGH DOSE DN
SPIRA SMOKERS LUNG CANCER UP
BOYLAN MULTIPLE MYELOMA C CLUSTER DN
BIOCARTA ATM PATHWAY
ZHOU INFLAMMATORY RESPONSE FIMA UP
BOYLAN MULTIPLE MYELOMA PCA3 UP
CHASSOT SKIN WOUND
TIAN TNF SIGNALING VIA NFKB
GENTILE UV LOW DOSE UP
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
AMIT DELAYED EARLY GENES
HOFMANN MYELODYSPLASTIC SYNDROM LOW RISK DN
KRIGE AMINO ACID DEPRIVATION
PEREZ TP63 TARGETS
AMIT EGF RESPONSE 60 MCF10A
HINATA NFKB TARGETS FIBROBLAST UP
RHEIN ALL GLUCOCORTICOID THERAPY UP
NOJIMA SFRP2 TARGETS UP
MISSIAGLIA REGULATED BY METHYLATION UP
CHEN HOXA5 TARGETS 6HR UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
NCI ATF2 PATHWAY
NETPATH EGFR1 PATHWAY DOWN
LEONARD HYPOXIA
SESTO RESPONSE TO UV C1
DORN ADENOVIRUS INFECTION 32HR DN
LEE LIVER CANCER MYC TGFA UP
CROONQUIST STROMAL STIMULATION UP
HALMOS CEBPA TARGETS UP
CHANDRAN METASTASIS DN
BOYLAN MULTIPLE MYELOMA C DN
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D UP
BIOCARTA CCR5 PATHWAY
SAGIV CD24 TARGETS DN
SHAFFER IRF4 TARGETS IN MYELOMA VS MATURE B LYMPHOCYTE
SIMBULAN UV RESPONSE NORMAL UP
KHETCHOUMIAN TRIM24 TARGETS UP
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
DORN ADENOVIRUS INFECTION 12HR UP
VERNELL RETINOBLASTOMA PATHWAY DN
MAHADEVAN RESPONSE TO MP470 DN
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
TSAI RESPONSE TO RADIATION THERAPY
LIN NPAS4 TARGETS DN
BROWNE HCMV INFECTION 30MIN UP
HARRIS HYPOXIA
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA UP
AMIT EGF RESPONSE 20 HELA
KAN RESPONSE TO ARSENIC TRIOXIDE
BASSO CD40 SIGNALING UP
SWEET LUNG CANCER KRAS DN
TIAN TNF SIGNALING NOT VIA NFKB
MARZEC IL2 SIGNALING UP
NAGASHIMA NRG1 SIGNALING UP
SOUCEK MYC TARGETS
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 6
ENK UV RESPONSE EPIDERMIS DN
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
ZERBINI RESPONSE TO SULINDAC UP
FRASOR RESPONSE TO ESTRADIOL DN
BILBAN B CLL LPL DN
WANG ESOPHAGUS CANCER VS NORMAL UP
FRIDMAN SENESCENCE UP
WU HBX TARGETS 2 DN
GENTILE UV LOW DOSE DN
MAHADEVAN RESPONSE TO MP470 UP
RASHI RESPONSE TO IONIZING RADIATION 1
FERRARI RESPONSE TO FENRETINIDE UP
SHAFFER IRF4 MULTIPLE MYELOMA PROGRAM
BILD HRAS ONCOGENIC SIGNATURE
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
LEE LIVER CANCER ACOX1 UP
MENSE HYPOXIA UP
ELVIDGE HIF1A AND HIF2A TARGETS DN
WANG ESOPHAGUS CANCER PROGRESSION UP
AMIT EGF RESPONSE 60 HELA
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
BERENJENO TRANSFORMED BY RHOA FOREVER DN
AMUNDSON DNA DAMAGE RESPONSE TP53
CHEN HOXA5 TARGETS 9HR UP
DAZARD UV RESPONSE CLUSTER G2
LEE SP4 THYMOCYTE
RORIE TARGETS OF EWSR1 FLI1 FUSION UP
WANG RECURRENT LIVER CANCER DN
AMIT SERUM RESPONSE 40 MCF10A
SEKI INFLAMMATORY RESPONSE LPS UP
HELLER HDAC TARGETS SILENCED BY METHYLATION UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
HELLER SILENCED BY METHYLATION DN
LEE RECENT THYMIC EMIGRANT
MURAKAMI UV RESPONSE 6HR UP
BUYTAERT PHOTODYNAMIC THERAPY STRESS UP
SENESE HDAC1 AND HDAC2 TARGETS UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D DN
WANG METHYLATED IN BREAST CANCER
XU HGF TARGETS INDUCED BY AKT1 6HR
ONDER CDH1 TARGETS 2 DN
SENESE HDAC1 TARGETS UP
MAINA VHL TARGETS DN
INGA TP53 TARGETS
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
UDAYAKUMAR MED1 TARGETS DN
KIM WT1 TARGETS UP
SENESE HDAC3 TARGETS UP
ONDER CDH1 TARGETS 1 DN
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
KOBAYASHI EGFR SIGNALING 6HR DN
HESS TARGETS OF HOXA9 AND MEIS1 DN
DASU IL6 SIGNALING UP
ELVIDGE HYPOXIA BY DMOG UP
AMIT EGF RESPONSE 120 MCF10A
CHIBA RESPONSE TO TSA UP
HOFMANN MYELODYSPLASTIC SYNDROM RISK UP
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
ZUCCHI METASTASIS DN
LU IL4 SIGNALING
BRUECKNER TARGETS OF MIRLET7A3 UP
BERENJENO ROCK SIGNALING NOT VIA RHOA DN
PRAMOONJAGO SOX4 TARGETS UP
WATTEL AUTONOMOUS THYROID ADENOMA DN
KIM WT1 TARGETS 8HR UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
LU TUMOR ENDOTHELIAL MARKERS UP
ELVIDGE HIF1A TARGETS DN
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
yersinia enterocolitica p60 bl6mycobacterium tuberculosisstreptococcus pneumoniae tigr4GeneSet Name
0.00000 0.00602 0.00001NETPATH_IL_1_PATHWAY_UP
0.00010 0.00002 0.00000NETPATH_TNF_ALPHA_PATHWAY_DOWN
0.00994 0.00008 0.07061NETPATH_IL_2_PATHWAY_UP
0.00010 0.01106 0.00685NETPATH_IL_4_PATHWAY_UP
0.00040 0.00000 0.00001GERY_CEBP_TARGETS
0.00146 0.00000 0.01938NETPATH_IL_4_PATHWAY_DOWN
0.00015 0.00019 0.00001NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.00000 0.00000 0.00000NETPATH_IL_6_PATHWAY_UP
0.00038 0.01945 0.00000NETPATH_EGFR1_PATHWAY_UP
0.09285 0.00813 0.00000NETPATH_WNT_PATHWAY_UP
0.00709 0.00856 0.00009NETPATH_IL_7_PATHWAY_UP
0.00000 0.00171 0.00810NETPATH_IL_3_PATHWAY_UP
0.00711 0.00000 0.00002NETPATH_IL_5_PATHWAY_UP
0.00021 0.00002 0.00058GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00016 0.08229 0.05141NETPATH_IL_9_PATHWAY_UP
0.00010 0.00132 0.00006MAHAJAN_RESPONSE_TO_IL1A_UP
0.01562 0.00120 0.08490LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.03690 0.00382 0.00000VANHARANTA_UTERINE_FIBROID_DN
0.05687 0.02638 0.00051CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.15490 0.00035 0.00000VARELA_ZMPSTE24_TARGETS_UP
0.00019 0.00015 0.00000CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.04211 0.13556 0.00292TENEDINI_MEGAKARYOCYTE_MARKERS
0.04591 0.00000 0.00796LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00297 0.00000 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00029 0.00000 0.15403LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.16659 0.02883 0.00958BASAKI_YBX1_TARGETS_DN
0.00543 0.00196 0.02026LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.04740 0.03217 0.02206ODONNELL_TFRC_TARGETS_UP
0.00031 0.00052 0.00000ELVIDGE_HYPOXIA_UP
0.03636 0.15708 0.19106GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.11700 0.00205 0.03413SESTO_RESPONSE_TO_UV_C0
0.00563 0.00217 0.08439IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.08183 0.02313 0.00046VALK_AML_CLUSTER_1
0.00021 0.00000 0.00000AMIT_EGF_RESPONSE_40_HELA
0.10787 0.01530 0.01028MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP
0.01900 0.00136 0.11902JEON_SMAD6_TARGETS_UP
0.05264 0.00125 0.00206LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT
0.00184 0.00000 0.00077THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.00708 0.00000 0.07760TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.01867 0.00199 0.00024TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.12093 0.07983 0.00130BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.00000 0.00000 0.00741HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.00341 0.00008 0.00001DORN_ADENOVIRUS_INFECTION_48HR_DN
0.17439 0.02144 0.00726KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.00058 0.00060 0.02561KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.08169 0.00021 0.09859OSADA_ASCL1_TARGETS_DN
0.00000 0.00001 0.00000AMIT_SERUM_RESPONSE_60_MCF10A
0.00178 0.00479 0.00456DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN
0.00201 0.00002 0.00090DUTTA_APOPTOSIS_VIA_NFKB
0.10560 0.00022 0.00000GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.00018 0.00000 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.14426 0.00000 0.17933DER_IFN_GAMMA_RESPONSE_UP
0.02147 0.00477 0.11158RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
0.00609 0.04672 0.00001SEMENZA_HIF1_TARGETS
0.15482 0.00205 0.00004NCI_NFAT_TFPATHWAY
0.00000 0.00002 0.00172ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.14315 0.00116 0.15086RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.00026 0.10086 0.00000ONDER_CDH1_TARGETS_3_DN
0.00032 0.00000 0.00000GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.00029 0.00000 0.00000AMIT_EGF_RESPONSE_120_HELA
0.07528 0.03099 0.05739BIOCARTA_RANKL_PATHWAY
0.06859 0.00880 0.00565DANG_REGULATED_BY_MYC_DN
0.02317 0.13415 0.06462VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
0.10917 0.02002 0.05863NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.01128 0.00196 0.00000DAZARD_RESPONSE_TO_UV_NHEK_UP
0.00050 0.00000 0.18322MCLACHLAN_DENTAL_CARIES_UP
0.01519 0.00019 0.00002WINTER_HYPOXIA_METAGENE
0.02695 0.00756 0.00103GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.03258 0.00177 0.07628NEWMAN_ERCC6_TARGETS_UP
0.00000 0.00000 0.00000PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.00305 0.00911 0.00114SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.00056 0.00000 0.00001GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.00000 0.00000 0.01424FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00563 0.00014 0.09181LEE_LIVER_CANCER_E2F1_UP
0.06979 0.00011 0.01378TAVOR_CEBPA_TARGETS_UP
0.00000 0.00000 0.09452GAURNIER_PSMD4_TARGETS
0.12090 0.04549 0.00312KERLEY_RESPONSE_TO_CISPLATIN_UP
0.00980 0.00117 0.00028SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.00000 0.00000 0.05005ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.00000 0.00002 0.00000GESERICK_TERT_TARGETS_DN
0.02692 0.02660 0.06315SUNG_METASTASIS_STROMA_UP
0.06583 0.03994 0.05146NETPATH_TGFBETA_RECEPTOR_PATHWAY_DOWN
0.05226 0.12700 0.08108NGUYEN_NOTCH1_TARGETS_DN
0.11573 0.05159 0.13640CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP
0.00007 0.00013 0.00000AMIT_SERUM_RESPONSE_120_MCF10A
0.00222 0.00000 0.00000BROWNE_HCMV_INFECTION_2HR_UP
0.19218 0.09475 0.18876NETPATH_IL_3_PATHWAY_DOWN
0.06899 0.05489 0.19961SASSON_RESPONSE_TO_GONADOTROPHINS_DN
0.00061 0.00000 0.00000DORN_ADENOVIRUS_INFECTION_24HR_DN
0.17655 0.01693 0.00000HALMOS_CEBPA_TARGETS_DN
0.13455 0.03003 0.15591ZIRN_TRETINOIN_RESPONSE_UP
0.00078 0.00000 0.00000SESTO_RESPONSE_TO_UV_C3
0.03292 0.04141 0.01335FALVELLA_SMOKERS_WITH_LUNG_CANCER
0.00000 0.00000 0.01022VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.05158 0.00002 0.00000AMIT_EGF_RESPONSE_40_MCF10A
0.04624 0.00000 0.00015BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.00109 0.00000 0.03793GEISS_RESPONSE_TO_DSRNA_UP
0.00272 0.00000 0.00170GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.11365 0.08955 0.00000NCI_P53DOWNSTREAMPATHWAY
0.09809 0.00487 0.09063CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_RPL6_RPL30_RPS13_CHUK_DDX3X_NFKB2_NFKBIB_REL_IKBKG_NFKB1_MAP3K8_RELB_GLG1_NFKBIA_RELA_TNIP2__GTF2I
0.08547 0.13562 0.00050GENTILE_UV_HIGH_DOSE_DN
0.04515 0.04454 0.00005SPIRA_SMOKERS_LUNG_CANCER_UP
0.00240 0.04451 0.01366BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN
0.09780 0.13575 0.01950BIOCARTA_ATM_PATHWAY
0.00000 0.00047 0.02569ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.01542 0.15706 0.01305BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
0.07095 0.00066 0.00000CHASSOT_SKIN_WOUND
0.00016 0.00000 0.00001TIAN_TNF_SIGNALING_VIA_NFKB
0.00394 0.17564 0.00028GENTILE_UV_LOW_DOSE_UP
0.00058 0.13990 0.01752LEE_LIVER_CANCER_HEPATOBLAST
0.00000 0.00000 0.00000NAGASHIMA_EGF_SIGNALING_UP
0.06744 0.00001 0.00000AMIT_DELAYED_EARLY_GENES
0.04570 0.00619 0.00046HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN
0.01090 0.00064 0.00068KRIGE_AMINO_ACID_DEPRIVATION
0.05482 0.16246 0.17915PEREZ_TP63_TARGETS
0.00000 0.00004 0.00000AMIT_EGF_RESPONSE_60_MCF10A
0.00034 0.00000 0.00038HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.19873 0.00003 0.00381RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.00037 0.00000 0.00000NOJIMA_SFRP2_TARGETS_UP
0.00038 0.00000 0.05746MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.01499 0.00079 0.00007CHEN_HOXA5_TARGETS_6HR_UP
0.02220 0.00000 0.00812SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00000 0.00000 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.05363 0.06127 0.00028NCI_ATF2_PATHWAY
0.10574 0.00000 0.12236NETPATH_EGFR1_PATHWAY_DOWN
0.01346 0.01105 0.00001LEONARD_HYPOXIA
0.01204 0.01198 0.00117SESTO_RESPONSE_TO_UV_C1
0.00369 0.00008 0.00000DORN_ADENOVIRUS_INFECTION_32HR_DN
0.02194 0.00029 0.14214LEE_LIVER_CANCER_MYC_TGFA_UP
0.00954 0.00025 0.00000CROONQUIST_STROMAL_STIMULATION_UP
0.00022 0.01212 0.00000HALMOS_CEBPA_TARGETS_UP
0.12846 0.00956 0.00003CHANDRAN_METASTASIS_DN
0.04754 0.00171 0.00574BOYLAN_MULTIPLE_MYELOMA_C_DN
0.00069 0.00000 0.12061TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.10323 0.05863 0.17164BIOCARTA_CCR5_PATHWAY
0.18844 0.00000 0.00002SAGIV_CD24_TARGETS_DN
0.09938 0.05116 0.00103SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
0.13433 0.04602 0.00048SIMBULAN_UV_RESPONSE_NORMAL_UP
0.05355 0.00000 0.02288KHETCHOUMIAN_TRIM24_TARGETS_UP
0.03385 0.01382 0.00068GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.00175 0.00008 0.00004DORN_ADENOVIRUS_INFECTION_12HR_UP
0.07021 0.02203 0.07864VERNELL_RETINOBLASTOMA_PATHWAY_DN
0.00072 0.00000 0.00000MAHADEVAN_RESPONSE_TO_MP470_DN
0.13271 0.00000 0.07880RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.01450 0.00000 0.19290TSAI_RESPONSE_TO_RADIATION_THERAPY
0.01909 0.04086 0.00003LIN_NPAS4_TARGETS_DN
0.10027 0.00010 0.00102BROWNE_HCMV_INFECTION_30MIN_UP
0.00029 0.00067 0.00000HARRIS_HYPOXIA
0.02263 0.00000 0.09743FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.02538 0.00000 0.00002DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.02559 0.00577 0.00000CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.18824 0.00486 0.00019AMIT_EGF_RESPONSE_20_HELA
0.00165 0.00571 0.00024KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.00018 0.00000 0.01887BASSO_CD40_SIGNALING_UP
0.06073 0.19250 0.18850SWEET_LUNG_CANCER_KRAS_DN
0.00683 0.00011 0.00000TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.00021 0.00127 0.01084MARZEC_IL2_SIGNALING_UP
0.00000 0.00000 0.00000NAGASHIMA_NRG1_SIGNALING_UP
0.00018 0.02521 0.02991SOUCEK_MYC_TARGETS
0.06778 0.00290 0.08094YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6
0.10880 0.00582 0.00050ENK_UV_RESPONSE_EPIDERMIS_DN
0.00000 0.00228 0.04093TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.05840 0.04554 0.00038ZERBINI_RESPONSE_TO_SULINDAC_UP
0.02087 0.05936 0.00295FRASOR_RESPONSE_TO_ESTRADIOL_DN
0.00270 0.01866 0.00001BILBAN_B_CLL_LPL_DN
0.03028 0.00019 0.16764WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.17993 0.00067 0.06538FRIDMAN_SENESCENCE_UP
0.16824 0.10873 0.00343WU_HBX_TARGETS_2_DN
0.00320 0.19320 0.00037GENTILE_UV_LOW_DOSE_DN
0.00018 0.00004 0.05724MAHADEVAN_RESPONSE_TO_MP470_UP
0.12899 0.00000 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_1
0.01472 0.00018 0.00024FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.00394 0.00240 0.02086SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.00000 0.00000 0.00000BILD_HRAS_ONCOGENIC_SIGNATURE
0.00000 0.00000 0.13850LIANG_SILENCED_BY_METHYLATION_2
0.06189 0.00000 0.00000DAUER_STAT3_TARGETS_UP
0.02321 0.00473 0.10301LEE_LIVER_CANCER_ACOX1_UP
0.17416 0.00000 0.00000MENSE_HYPOXIA_UP
0.04573 0.04633 0.01450ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.02833 0.00139 0.03617WANG_ESOPHAGUS_CANCER_PROGRESSION_UP
0.00019 0.00000 0.00000AMIT_EGF_RESPONSE_60_HELA
0.08832 0.00008 0.00000ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.00332 0.08977 0.00046BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.13590 0.02253 0.00083AMUNDSON_DNA_DAMAGE_RESPONSE_TP53
0.00807 0.00006 0.00003CHEN_HOXA5_TARGETS_9HR_UP
0.01250 0.01541 0.00000DAZARD_UV_RESPONSE_CLUSTER_G2
0.05402 0.00049 0.00046LEE_SP4_THYMOCYTE
0.05513 0.14786 0.02565RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.10907 0.00619 0.01420WANG_RECURRENT_LIVER_CANCER_DN
0.00000 0.00000 0.00000AMIT_SERUM_RESPONSE_40_MCF10A
0.00000 0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00993 0.00601 0.16607HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
0.00398 0.00000 0.00000GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00489 0.00028 0.00250CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.00000 0.00000 0.00001ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.02310 0.00045 0.06732HELLER_SILENCED_BY_METHYLATION_DN
0.03654 0.00813 0.02029LEE_RECENT_THYMIC_EMIGRANT
0.12076 0.17085 0.02795MURAKAMI_UV_RESPONSE_6HR_UP
0.02031 0.00001 0.00109BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
0.01129 0.01303 0.05989SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.10800 0.00300 0.15405TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
0.00162 0.01939 0.00000WANG_METHYLATED_IN_BREAST_CANCER
0.02501 0.00001 0.05262XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.00022 0.00500 0.10479ONDER_CDH1_TARGETS_2_DN
0.01901 0.04425 0.08992SENESE_HDAC1_TARGETS_UP
0.16597 0.00177 0.11905MAINA_VHL_TARGETS_DN
0.06039 0.12410 0.00001INGA_TP53_TARGETS
0.00030 0.00000 0.00000HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.06418 0.00070 0.00054UDAYAKUMAR_MED1_TARGETS_DN
0.00039 0.00007 0.00001KIM_WT1_TARGETS_UP
0.00979 0.00552 0.11682SENESE_HDAC3_TARGETS_UP
0.00405 0.07350 0.00114ONDER_CDH1_TARGETS_1_DN
0.00000 0.00000 0.00000UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.04783 0.00020 0.00001KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.00006 0.00000 0.00000HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.00177 0.00006 0.00007DASU_IL6_SIGNALING_UP
0.00028 0.00043 0.00000ELVIDGE_HYPOXIA_BY_DMOG_UP
0.00086 0.03451 0.00000AMIT_EGF_RESPONSE_120_MCF10A
0.01907 0.05981 0.03030CHIBA_RESPONSE_TO_TSA_UP
0.12377 0.00478 0.00964HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP
0.00037 0.00002 0.00000GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00000 0.00000 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.04370 0.00039 0.00000ZUCCHI_METASTASIS_DN
0.00176 0.02153 0.17647LU_IL4_SIGNALING
0.04236 0.06983 0.01685BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.01126 0.00059 0.03483BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
0.02844 0.00000 0.00000PRAMOONJAGO_SOX4_TARGETS_UP
0.01530 0.04327 0.00001WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
0.06776 0.00125 0.00887KIM_WT1_TARGETS_8HR_UP
0.00000 0.00000 0.00000PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.14239 0.03057 0.00069YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.07743 0.15152 0.16737LU_TUMOR_ENDOTHELIAL_MARKERS_UP
0.10495 0.04594 0.03264ELVIDGE_HIF1A_TARGETS_DN